For the sake of coherence, this account is written chiefly in the person of the first author, though it represents the joint recollection of both authors, who were party to the cloning of Lps. Numerous dates and events were reconstructed based upon meticulous records kept by Betsy Layton, Administrative Assistant to the first author, who also participated in the cloning effort. Scientific citations are indicated in superscript and are to be found under References; comments are indicated as {n} and are to be found under Notes (section before References).
References
1.
Heppner G., Weiss DWHigh susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J Bacteriol1965; 90: 696—703.
2.
Poltorak A., He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
3.
Herodotus.The Histories, Book I. (Translated by Grene D.). Chicago : University of Chicago Press, 1987 ; 33.
4.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JCCD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990; 249: 1431—1433.
5.
Juan Tsc, Hailman E., Kelley MJ, Wright SD, Lichenstein HSIdentification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J Biol Chem1995; 270: 17237—17242.
6.
Leturcq DJ, Moriarty AM, Talbott G., Winn RK, Martin TR, Ulevitch RJAntibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest1996; 98: 1533—1538.
7.
Haziot A., Ferrero E., Kontgen F. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity1996; 4: 407—414.
8.
Righi M., Pierani A., Boglia A. et al. Generation of new oncogenic murine retroviruses by cotransfection of cloned AKR and MH2 proviruses. Oncogene1989; 4: 223—230.
9.
Pirami L., Stockinger B., Corradin SB et al. Mouse macrophage clones immortalized by retroviruses are functionally heterogeneous. Proc Natl Acad Sci USA1991 ; 88: 7543—7547.
10.
Coutinho A. , Forni L., Melchers F., Watanabe T.Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur J Immunol1977; 7: 325—328.
11.
Coutinho A. , Meo T.Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics1978; 7: 17—24.
12.
Watson J., Riblet R., Taylor BAThe response of recombinant inbred strains of mice to bacterial lipopolysaccharides . J Immunol1977; 118: 2088—2093.
13.
Watson J., Kelly K., Largen M., Taylor BAThe genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol1978; 120: 422—424.
14.
Rosenstreich DL, Vogel SN, Jacques AR, Wahl LM, Oppenheim JJMacrophage sensitivity to endotoxin. Genetic control by a single codominant gene. J Immunol1978; 121: 1664—1670.
15.
Freudenberg MA , Kumazawa Y., Meding S., Langhorne J., Galanos C.Gamma interferon production in endotoxin-responder and -nonresponder mice during infection. Infect Immun1991; 59: 3484—3491.
16.
Yaegashi Y., Nielsen P., Sing A., Galanos C., Freudenberg MAInterferon beta, a cofactor in the interferon gamma production induced by Gram-negative bacteria in mice. J Exp Med1995; 181: 953—960.
17.
Katschinski T. , Galanos C., Coumbos A., Freudenberg MAGamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun1992; 60: 1994—2001.
18.
Takakuwa T., Knopf HP, Sing A., Carsetti R., Galanos C., Freudenberg MAInduction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice. Eur J Immunol1996; 26: 2686—2692.
19.
Beutler B., Milsark IW, Cerami A.Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science1985; 229: 869—871.
20.
Michalek SM , Moore RN, McGhee JR, Rosenstreich DL, Mergenhagen SEThe primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J Infect Dis1980; 141: 55—63.
21.
Freudenberg MA, Keppler D., Galanos C.Requirement for lipopolysaccharide-responsive macrophages in galactosamineinduced sensitization to endotoxin. Infect Immun1986; 51: 891—895.
22.
Dietrich W. , Katz H., Lincoln SE et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics1992; 131: 423—447.
23.
Vogel SNThe Lps gene: insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation. In: Beutler B. (Ed) Tumor Necrosis Factors: The Molecules and their Emerging Role in Medicine. New York: Raven, 1992; 485—513.
24.
Vogel SN, Wax JS, Perera PY, Padlan C., Potter M., Mock BAConstruction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene. Infect Immun1994; 62: 4454—4459.
25.
Poltorak A. , Smirnova I., He XL et al. Genetic and physical mapping of the Lps locus — identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cell Mol Dis1998; 24: 340—355.
26.
Rinchik EM, Bell JA, Hunsicker PR, Friedman JM, Jackson IJ, Russell LBMolecular genetics of the brown (b)-locus region of mouse chromosome 4. I. Origin and molecular mapping of radiation- and chemical-induced lethal brown deletions. Genetics1994; 137: 845—854.
27.
Bell JA, Rinchik EM, Raymond S., Suffolk R., Jackson IJA high-resolution map of the brown (b, Tyrp1) deletion complex of mouse chromosome 4. Mamm Genome1995; 6: 389—395.
28.
Qureshi ST, Lariviere L., Leveque G. et al. Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). J Exp Med1999; 189: 615—625.
29.
Qureshi ST, Lariviere L., Leveque G. et al. Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4) [correction]. J Exp Med1999; 189: 1519—1520.
30.
Qureshi ST, Larivière L., Sebastiani G. et al. A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics1996; 31: 283—294.
31.
Nomura N., Miyajima N., Sazuka T. et al. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001—KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res1994; 1: 27—35.
32.
Lemaitre B. , Nicolas E., Michaut L., Reichhart JM, Hoffmann JAThe dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell1996; 86: 973—983.
33.
Medzhitov R. , Preston-Hurlburt P., Janeway Jr CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity [see comments]. Nature1997; 388: 394—397.
34.
Taguchi T., Mitcham JL, Dower SK, Sims JE, Testa JRChromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genomics1996; 32: 486—488.
35.
Rock FL, Hardiman G., Timans JC, Kastelein RABazan JFA family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA1998; 95: 588—593.
Kang AD, Wong PM, Chen H., Castagna R., Chung SW, Sultzer BMRestoration of lipopolysaccharide-mediated B-cell response after expression of a cDNA encoding a GTP-binding protein. Infect Immun1996; 64: 4612—4617.
38.
Thieblemont N., Wright SDMice genetically hyporesponsive to lipopolysaccharide (LPS) exhibit a defect in endocytic uptake of LPS and ceramide. J Exp Med1997; 185: 2095—2100.
39.
Chaudhary PM , Ferguson C., Nguyen V. et al. Cloning and characterization of two Toll/interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood1998; 91: 4020—4027.
40.
Yang R-B., Mark MR, Gray A. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature1998; 395: 284—288.
41.
Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide . J Exp Med1998; 188: 2091—2097.
42.
Gerard C.For whom the bell tolls. Nature1998; 395: 217—219.
43.
Takeuchi O. , Hoshino K., Kawai T. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components . Immunity1999; 11: 443—451.
44.
Kuhns DB, Long Priel DA, Gallin JIEndotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol1997; 158: 3959—3964.
45.
Takeuchi O. , Kaufmann A., Grote K. et al. Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol2000; 164: 554—557.
46.
Poltorak A. , Ricciardi-Castagnoli P., Citterio A., Beutler B.Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc Natl Acad Sci USA2000; 97: 2163—2167.
47.
Lien E., Means TK, Heine H. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest2000; 105: 497—504.
48.
Du X., Poltorak A., Wei Y., Beutler B.Three novel mammalian Toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Network2000; In press.
49.
Chuang T-H. , Ulevitch RJCloning and characterization of a subfamily of human toll-like receptors: hTLR7, hTLR8, and hTLR9. Eur Cytokine Network2000; In press.
50.
Shimazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med1999; 189: 1777—1782.
51.
Wong PM, Kang A., Chen H. et al. Lps(d)/Ran of endotoxin-resistant C3H/HeJ mice is defective in mediating lipopolysaccharide endotoxin responses. Proc Natl Acad Sci USA1999; 96: 11543—11548.
52.
Yuan Q., Zhao F., Chung SW et al. Dominant negative downregulation of endotoxin-induced tumor necrosis factor alpha production by Lpsd/Ran. Proc Natl Acad Sci USA2000; 97: 2852—2857.
53.
Vogel SN, Johnson D., Perera P-Y. et al. Functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation . J Immunol1999; 162: 5666—5670.
54.
Poltorak A., Smirnova I., Clisch R., Beutler B.Limits of a deletion spanning Tlr4 in C57BL/10ScCr mice. J Endotoxin Res2000; 6: 51—56.
55.
Watanabe T., Ohara J.Functional nuclei of LPS-nonresponder C3H/HeJ mice after transfer into LPS-responder C3H/HeN cells by cell fusion. Nature1981; 290: 58—59.
56.
Vogel SN, Weedon LL, Moore RN, Rosenstreich DLCorrection of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule. J Immunol1982; 128: 380—387.
57.
Vogel SN, Finbloom DS, English KE, Rosenstreich DL, Langreth SGInterferon-induced enhancement of macrophage Fc receptor expression: beta-interferon treatment of C3H/HeJ macrophages results in increased numbers and density of Fc receptors. J Immunol1983; 130: 1210—1214.
58.
Beutler B., Tkacenko V., Milsark IW, Krochin N., Cerami A.The effect of interferon-gamma on cachectin expression by mononuclear phagocytes: reversal of the lps-d (endotoxin resistance) phenotype. J Exp Med1986; 164: 1791—1796.
59.
Cabeza-Arvelaiz Y., Dillen C., Heremans H. et al. Cholera and pertussis exotoxins protect mice against the lethal Schwartzman reaction and antagonize the effects of lipopolysaccharide on second messenger systems. Lymphokine Res1990; 9: 125—135.
60.
Ziegler SF, Wilson CB, Perlmutter RMAugmented expression of a myeloid-specific protein tyrosine kinase gene (hck) after macrophage activation. J Exp Med1988 ; 168: 1801—1810.
Dong Z., O'Brian CA, Fidler IJActivation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity. J Leukocyte Biol1993; 53: 53—60.
63.
Wightman PD , Raetz Crh.The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. J Biol Chem1984; 259: 10048—10052.
64.
Sultzer BM, Castagna R., Bandekar J., Wong P.Lipopolysaccharide nonresponder cells: the C3H/HeJ defect. Immunobiology1993; 187: 257—271.
65.
Ulevitch RJRecognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol1993; 53: 267—289.
66.
Maeda T., Wurgler-Murphy SM, Saito H.A two-component system that regulates an osmosensing MAP kinase cascade in yeast [see comments]. Nature1994; 369: 242—245.
Joseph CK, Wright SD, Bornmann WG et al. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biol Chem1994; 269: 17606—17610.
73.
Smirnova I. , Poltorak A., Chan Ekl, McBride C., Beutler B.Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4). Genome Biol2000; 1: 1—10.
